Genomill
@genomill.com
Genomill is unlocking the true potential of NGS for everyday healthcare with Geno1®, a radically rethought sequencing library preparation based on circular DNA and PCR-free workflows. It combines hybrid-capture–like performance with amplicon-level simplicity: targeted sequencing with minimal steps and the fastest turn-around time compared to other commercial tests. This simplicity makes sequencing faster to run, easier to automate, and practical even in low-infrastructure environments. By enabling decentralized sequencing without compromising sensitivity or scalability, Geno1® changes how next-generation sequencing can be applied in real-world healthcare. Find out more at www.genomill.com
Genomill's Company Logos
Genomill's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#D8D5FF
Fog
216, 213, 255
244, 100, 92
15, 16, 0, 0
#AAAAAA
Silver Chalice
170, 170, 170
0, 0, 67
0, 0, 0, 33
#02030D
Black Pearl
2, 3, 13
235, 73, 3
85, 77, 0, 95
About Genomill
Genomill is a pioneering precision diagnostics company that is redefining the field of liquid biopsies. Their vision is to become a leader in transforming precision diagnostics and enabling the full potential of liquid biopsies worldwide. Genomill aims to remove the barriers for global access to liquid biopsies in oncology, infectious disease detection, and other areas.
Their proprietary Geno1® pre-sequencing platform, based on Next-Generation-Sequencing (NGS) technology, is at the forefront of this revolution. Geno1® offers significant improvements in costs, accuracy, performance, and scalability, thanks to its unique combination of molecular biology, robotics, NGS, and data interpretation. It truly unlocks the future of liquid biopsies.
Genomill is actively exploring partnerships and collaborations in the field of oncology and other verticals, such as infectious diseases, NIPT, and antibiotic resistance. They offer Geno1® for out-licensing and are seeking collaborators to harness this game-changing technology. With a team of experts in molecular biology, bioinformatics, and clinical research, Genomill is poised to revolutionize precision diagnostics and improve patient outcomes.
Join their journey and be a part of this groundbreaking technology today!
Company type
Privately Held
Year founded
2016
Company size
11-50 employees
